News Brexit decision hits European pharma shares Shares of leading UK companies have plummeted after the country’s decision to leave the European Union.
News British pharma, biotech reiterate ‘Remain’ support On the eve of the hugely important referendum, the result is too close to call.
Articles Brexit would be a blow for UK life sciences – regulators and... The British public is still split over Brexit – but pharma is warning of potentially serious consequences if the country votes 'Leave' on 23 June. Andrew McConaghie reports.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
